Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
fampridine, Quantity: 10 mg
Arrotex Pharmaceuticals Pty Ltd
Fampridine
Tablet, modified release
Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; macrogol 8000; polyvinyl alcohol; titanium dioxide; hypromellose; purified talc; microcrystalline cellulose
Oral
56 tablets
(S4) Prescription Only Medicine
FAMPRIDINE MR APOTEX modified release tablets are indicated for the symptomatic improvement of walking ability in adult patients with Multiple Sclerosis who have shown improvement after 8 weeks of treatment.
Visual Identification: White coloured, oval-shaped, biconvex film-coated tablets engraved "APO" on one side and "DAL 10" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-08-25